Becton Dickinson closes GenOhm acquisition:
This article was originally published in Clinica
Executive Summary
Becton Dickinson (BD) has completed its acquisition of GeneOhm Sciences, the San Diego, California-based developer of rapid DNA tests for bacterial organisms. BD, of Franklin Lakes, New Jersey, agreed to buy GeneOhm in January for $230m, as well as additional incentives of up to $25m. GeneOhm's technologies include tests that detect bacteria known to cause healthcare-associated infections (HAIs).